PHAR 303 FPD - diabetics

Card Set Information

Author:
stephjg
ID:
235884
Filename:
PHAR 303 FPD - diabetics
Updated:
2013-09-22 19:33:02
Tags:
frequently prescribed drugs
Folders:

Description:
diabetic meds
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user stephjg on FreezingBlue Flashcards. What would you like to do?


  1. gliclazide - brand name
    Diamicron
  2. Diamicron - ingredients
    gliclazide
  3. gliclazide - therapeutic category
    Oral hypoglycemic (sulfonylurea)
  4. gliclazide - schedule
    1
  5. gliclazide -strengths and dosage forms
    Tablets: 30mg (modified release (MR)), 80mg
  6. glyburide - brand name
    Diabeta
  7. Diabeta - ingredients
    glyburide
  8. glyburide - therapeutic category
    Oral hypoglycemic (sulfonylurea)
  9. glyburide - schedule
    1
  10. glyburide - RDP?
    no
  11. glyburide - strengths and dosage forms
    Tablets: 2.5, 5mg
  12. oral hypoglycemic (sulfonylurea) - indications
    Control of hyperglycemia in DM 2 patients (non-insulin dependent, failed glycemic control with diet/exercise
  13. oral hypoglycemic (sulfonylurea) - contraindications
    Hypersensitivity and pts with unstable diabetes or insulin-dependent diabetes and pts with a sulfa allergy
  14. Insulin (human biosynthetic) - brand names
    • Humulin-N
    • Humulin-R
    • Novolin ge NPH
    • Novolin ge Toronto
  15. insulin (human) - therapeutic category
    antidiabetic
  16. insulin (human) - schedule
    2
  17. insulin (human) - RDP?
    n/a
  18. insulin (human) - strengths/dosage forms
    • Strength: 100 units/mL
    • Dosage forms: 10mL vial, 3 mL cartridge
  19. insulin (human) - indications
    • Treatment of insulin-requiring diabetic patients.
    • Humulin R – only for emergencies (diabetic coma/pre-coma)
  20. insulin (human) - contraindications
    hypersensitivity and patients with hypoglycemia
  21. insulin glargine - brand name
    Lantus
  22. lantus - ingredients
    insulin glargine
  23. insulin glargine -therapeutic category
    antidiabetic
  24. insulin glargine - schedule
    2
  25. insulin glargine - RDP?
    n/a
  26. insulin glargine - strengths and dosage forms
    • Strength: 100 units/mL
    • Dosage forms: 10mL vial, 3 mL cartridge (subcutaneous injection)
  27. insulin glargine - indications
    Treatment of pts over 17 years old with DM 1 or DM 2 or DM1 pediatric pts who require basal (long-acting) insulin for control of hyperglycemia.
  28. insulin glargine - contraindications
    hypersensitivity
  29. metformin HCl - brand name
    Glucophage
  30. Glucophage - ingredients
    metformin HCl
  31. metformin HCl - therapeutic category
    Oral hypoglycemic (biguanide)
  32. metformin HCl - schedule
    1
  33. metformin HCl - RDP?
    no
  34. metformin HCl - strengths and dosage forms
    Tablet: 500, 850mg
  35. metformin HCl - indications
    Control hyperglycemia in DM 2 which cannot be controlled by diet management, exercise and weight reduction or when insulin therapy is not appropriate.
  36. metformin HCl - contraindications
    Hypersensitivity and unstable or insulin-dependent diabetes
  37. pioglitazone - brand name
    Actos
  38. Actos - ingredients
    pioglitazone
  39. pioglitazone - therapeutic category
    Oral hypoglycemic (insulin resistance reducing agent)
  40. pioglitazone - schedule
    1
  41. pioglitazone - RDP?
    no
  42. pioglitazone - strengths and dosage forms
    Tablet: 15, 30, 45mg
  43. pioglitazone - indications
    • Used to decrease
    • insulin resistance and blood glucose levels in pts with DM2 that are not controlled by diet and exercise alone
  44. pioglitazone - contraindications
    Hypersensitivity, pregnancy, cardiac pts and those with severe hepatic impairment
  45. insulin aspart - brand name
    NovoRapid
  46. NovoRapid- ingredients
    insulin aspart
  47. insulin aspart - schedule
    2
  48. insulin aspart - RDP?
    n/a
  49. insulin aspart - strengths and dosage forms
    Solution for injection, 100 units/mL (subcutaneous injection), 10 mL vial
  50. insulin aspart - therapeutic category
    antidiabetic
  51. insulin aspart - indications
    treatment of patients with diabetes mellitus who require insulin for the control of hyperglycemia
  52. insulin aspart - CIs
    hypersensitivity and pts with hypoglycemia
  53. insulin detemir - brand name
    levemir
  54. levemir - ingredients
    insulin detemir
  55. insulin detemir - therapeutic category
    antidiabetic
  56. insulin detemir - schedule
    2
  57. insulin detemir - RDP?
    n/a
  58. insulin detemir - strengths and dosage forms
    Solution for injection, 100 units/mL (subcutaneous injection), 3 ml cartridge
  59. insulin detemir - indications
    • treatment of adult patients with type 1 or type 2 DM who require a long-acting (basal) insulin for the control of hyperglycemia;
    • the treatment of pediatric patients with type 1 DM who require a long-acting (basal) insulin for the control of hyperglycemia.
    • the treatment of type 2 diabetes mellitus in combination with oral anti-diabetic agents (OADs) [metformin or sulfonylureas] in adult patients who are not in adequate metabolic control on OADs alone.
  60. insulin detemir - CIs
    hypersensitivity and pts with hypoglycemia
  61. insulin lispro - brand name
    Humalog
  62. humalog - ingredients
    insulin lispro
  63. insulin lispro - therapeutic category
    antidiabetic
  64. insulin lispro - schedule
    2
  65. insulin lispro - RDP?
    n/a
  66. insulin lispro - strengths and dosage forms
    Solution for parenteral injection; 100 units/mL, vials of 3 mL and 10 mL
  67. insulin lispro - indications
    treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis, for use in conjunction with a longer acting human insulin
  68. insulin lispro - CIs
    hypersensitivity and pts with hypoglycemia
  69. metformin HCl-sitagliptan phosphate - brand name
    Janumet
  70. janumet - ingredients
    metformin HCl-sitagliptan phosphate
  71. metformin-sitagliptan - therapeutic category
    Oral hypoglycemic biguanide and dipeptidyl peptidase 4 (DPP-4) inhibitor
  72. metformin-sitagliptan - schedule
    1
  73. metformin-sitagliptan - RDP?
    no
  74. metformin-sitagliptan - strengths and dosage forms
    Tablet: 50 mg/500 mg, 50 mg/850 mg, 50 mg/1000 mg
  75. metformin-sitagliptan - indications
    an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus
  76. metformin-sitagliptan - CIs
    Hypersensitivity, unstable or insulin-dependent diabetes, pregnancy/breastfeeding, and excessive alcohol intake
  77. sitagliptan phosphate - brand name
    Januvia
  78. Januvia - ingredients
    sitagliptan phosphate
  79. sitagliptan - therapeutic category
    Oral hypoglycemic (dipeptidyl peptidase 4 (DPP-4) inhibitor)
  80. sitagliptan - schedule
    1
  81. sitagliptan - RDP?
    no
  82. sitagliptan - strengths and dosage forms
    Tablet: 25, 50 and 100 mg
  83. sitagliptan - indications
    an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus
  84. sitagliptan - CIs
    hypersensitivity

What would you like to do?

Home > Flashcards > Print Preview